Filing Details

Accession Number:
0001179110-14-017273
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-01 17:15:22
Reporting Period:
2014-11-26
Filing Date:
2014-12-01
Accepted Time:
2014-12-01 17:15:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1578845 Actavis Plc ACT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1536778 William Meury 1 Grand Canal Square, Docklands
Dublin 2 L2 00000
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, Par Value $0.0001 Acquisiton 2014-11-26 7,083 $90.06 86,489 No 4 M Direct
Ordinary Shares, Par Value $0.0001 Disposition 2014-11-26 4,550 $269.14 81,939 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares, Par Value $0.0001 Stock Option (Right to Buy) Disposition 2014-11-26 7,083 $0.00 7,083 $90.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-12-13 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $268.23 to $270.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. The option was fully vested and exercisable as of December 13, 2009.